Compare MGPI & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGPI | TNGX |
|---|---|---|
| Founded | 1941 | 2014 |
| Country | United States | United States |
| Employees | 617 | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 397.4M | 2.8B |
| IPO Year | 1994 | 2020 |
| Metric | MGPI | TNGX |
|---|---|---|
| Price | $18.60 | $19.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $30.00 | $18.75 |
| AVG Volume (30 Days) | 320.9K | ★ 3.7M |
| Earning Date | 04-30-2026 | 03-05-2026 |
| Dividend Yield | ★ 2.61% | N/A |
| EPS Growth | N/A | ★ 26.89 |
| EPS | N/A | ★ N/A |
| Revenue | $19,782,000.00 | ★ $62,384,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.11 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 48.29 |
| 52 Week Low | $16.45 | $1.04 |
| 52 Week High | $33.75 | $21.82 |
| Indicator | MGPI | TNGX |
|---|---|---|
| Relative Strength Index (RSI) | 43.57 | 66.38 |
| Support Level | $16.45 | $6.77 |
| Resistance Level | $26.44 | N/A |
| Average True Range (ATR) | 0.74 | 1.12 |
| MACD | 0.36 | 0.09 |
| Stochastic Oscillator | 77.50 | 54.44 |
MGP Ingredients Inc is a producer and supplier of distilled spirits, specialty wheat protein, and starch food ingredients based in the United States. It operates in three reportable segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Maximum revenue is generated from the Branded Spirits segment, which consists of a portfolio of brands that it produces through its distilleries and bottling facilities and sells to distributors or to state governments that directly control the sale of alcohol. MGP's branded spirits include various brands across numerous categories and price tiers, such as Penelope Bourbon, Yellowstone Bourbon, Minor Case Straight Rye Whiskey, Brady's Irish Cream, Exotico Tequila, Arrow Cordials, Canada House Canadian Whisky, Lady Bligh Rum, etc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.